Frequency and Prognostic Significance of MYD88 Mutations and MGMT Methylation in Primary Central Nervous System Diffuse Large B-Cell Lymphoma (PCNS-DLBCL)

被引：0
|
作者：
Zheng, M.
Perry, A.
Bierman, P. J.
Nasr, M. R.
Szwajcer, D.
Del Bigio, M.
Greiner, T. C.
机构：
[1] Univ Nebraska Med Ctr, Omaha, NE USA
[2] Univ Manitoba, Winnipeg, MB, Canada
来源：
MODERN PATHOLOGY | 2014年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1596
引用
收藏
页码：389A / 389A
页数：1
相关论文
共 50 条
  • [1] Frequency and Prognostic Significance of MYD88 Mutations and MGMT Methylation in Primary Central Nervous System Diffuse Large B-Cell Lymphoma (PCNS-DLBCL)
    Zheng, M.
    Perry, A.
    Bierman, P. J.
    Nasr, M. R.
    Szwajcer, D.
    Del Bigio, M.
    Greiner, T. C.
    LABORATORY INVESTIGATION, 2014, 94 : 389A - 389A
  • [2] Frequency of MYD88 and CD79B mutations, and MGMT methylation in primary central nervous system diffuse large B-cell lymphoma
    Zheng, Mei
    Perry, Anamarija M.
    Bierman, Philip
    Loberiza, Fausto, Jr.
    Nasr, Michel R.
    Szwajcer, David
    Del Bigio, Marc R.
    Smith, Lynette M.
    Zhang, Weiwei
    Greiner, Timothy C.
    NEUROPATHOLOGY, 2017, 37 (06) : 509 - 516
  • [3] Clinicopathologic Significance of MYD88 L265P Mutation in Diffuse Large B-Cell Lymphoma (DLBCL)
    Talaat, Ahmed
    El-Ashwah, Shaimaa
    Tharwat, Layla
    Eladl, Ahmed
    Shamaa, Sameh
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S430 - S430
  • [4] CD798 and MYD88 mutations in diffuse Large B-cell Lymphoma
    Kim, Yuil
    Ju, Hyunjeong
    Kim, Dong Hoon
    Yoo, Hae Yong
    Kim, Suk Jin
    Kim, Won Seog
    Ko, Young Hyeh
    HUMAN PATHOLOGY, 2014, 45 (03) : 556 - 564
  • [5] The Impact of MYD88 and/or CD798 Gene Mutations on Central Nervous System Relapse in Patients with Diffuse Large B-Cell Lymphoma
    Suzuki, Tomotaka
    Fujii, Keiichiro
    Matsunaga, Naohiro
    Sasaki, Hirokazu
    Kanamori, Takashi
    Asano, Arisa
    Kinoshita, Shiori
    Narita, Tomoko
    Masaki, Ayako
    Sanda, Takaomi
    Ri, Masaki
    Komatsu, Hirokazu
    Iida, Shinsuke
    Inagaki, Hiroshi
    BLOOD, 2024, 144 : 3075 - 3076
  • [6] Deciphering the Prognostic Significance of MYD88 and CD79B Mutations in Diffuse Large B-Cell Lymphoma: Insights into Treatment Outcomes
    Xie, Zucheng
    Qin, Yan
    Chen, Xinrui
    Yang, Sheng
    Yang, Jianliang
    Gui, Lin
    Liu, Peng
    He, Xiaohui
    Zhou, Shengyu
    Zhang, Changgong
    Tang, Le
    Shi, Yuankai
    TARGETED ONCOLOGY, 2024, 19 (03) : 383 - 400
  • [7] Clinical significance of MYD88 non-L265P mutations in diffuse large B-cell lymphoma
    Xie, Jialing
    Shen, Xia
    Shi, Qin
    Yi, Hongmei
    Ouyang, Binshen
    Zhang, Zhihan
    Gu, Yijin
    Dong, Lei
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (05) : 885 - 893
  • [8] Prognostic impact of MYD88 and TP53 mutations in diffuse large B Cell lymphoma
    Osama Abd El Hameed Ebid
    Lobna R. Ezz El Arab
    Amr S. Saad
    Mai Ezz El Din
    Nermeen Mostafa
    Menha Swellam
    Annals of Hematology, 2023, 102 : 3477 - 3488
  • [9] Prognostic impact of MYD88 and TP53 mutations in diffuse large B Cell lymphoma
    Ebid, Osama Abd El Hameed
    El Arab, Lobna R. Ezz
    Saad, Amr S.
    El Din, Mai Ezz
    Mostafa, Nermeen
    Swellam, Menha
    ANNALS OF HEMATOLOGY, 2023, 102 (12) : 3477 - 3488
  • [10] MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis
    Vermaat, Joost S.
    Somers, Sebastiaan F.
    de Wreede, Liesbeth C.
    Kraan, Willem
    de Groen, Ruben A. L.
    Schrader, Anne M. R.
    Kerver, Emile D.
    Scheepstra, Cornelis G.
    Berenschot, Henriette
    Deenik, Wendy
    Wegman, Jurgen
    Broers, Rianne
    De Boer, Jan-Paul D.
    Nijland, Marcel
    van Wezel, Tom
    Veelken, Hendrik
    Spaargaren, Marcel
    Cleven, Arjen H.
    Kersten, Marie Jose
    Pals, Steven T.
    HAEMATOLOGICA, 2020, 105 (02) : 424 - 434
12345